Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05288803 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
NotablePrimary completion pushed from Sep 30, 2026 to Mar 31, 2027Completion pushed from Mar 31, 2027 to Jun 30, 2027 · Secondary endpoints: details revised at 4 of 4 entries · Site contacts updated at 1 of 2 sites · 1 moreShow 4 more changesShow less
Completion pushed from Mar 31, 2027 to Jun 30, 2027
Secondary endpoints: details revised at 4 of 4 entries
Site contacts updated at 1 of 2 sites
Eligibility criteria shortened, about 4 words
NotablePrimary completion date: Mar 31, 2026 to Sep 30, 2026Completion date: Sep 30, 2026 to Mar 31, 2027 · Secondary endpoints: details revised at 4 of 4 entries · Site contacts updated at 2 of 2 sites · 1 morev6Show 4 more changesShow less
Completion date: Sep 30, 2026 to Mar 31, 2027
Secondary endpoints: details revised at 4 of 4 entries
NotablePrimary completion date: Mar 31, 2025 to Mar 31, 2026Completion date: Mar 31, 2026 to Sep 30, 2026 · Site details revised at 2 of 2 sitesv5Show 2 more changesShow less
Completion date: Mar 31, 2026 to Sep 30, 2026
Site details revised at 2 of 2 sites
MinorStudy sites: 1 to 2v4
MinorRe-verified, no change to tracked fieldsv3
NotableTrial status: Not Yet Recruiting to RecruitingSite details revisedv2Show 1 more changeShow less
Site details revised
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will examine the impact of a new clinical decision support tool for rehabilitation after total knee arthroplasty (TKA). Typically, TKA rehabilitation is generic with most patients receiving the same dosage and contents of rehabilitation despite notable diversity among patients who undergo TKA. The investigators clinical support decision tool is designed to help physical therapists tailor rehabilitation treatments and dosages to the individual needs, goals, and preferences of Veterans recovering from TKA. This study has the potential to improve Veterans' functional recovery after TKA, while simultaneously reducing the average number of physical therapy visits Veterans attend after surgery by tailoring rehabilitation dosage based upon need. This will ensure the Veterans Health Administration (VHA) has the resources and capacity to provide adequate rehabilitation to every Veteran seeking TKA in the VHA system. Additionally, if successful, this clinical decision support tool could be used to improve outcomes and access for additional patient populations in the future.